Perfluorodecanoic acid as a useful pharmacologic tool for the study of peroxisome proliferation

General Pharmacology

Volumn 27, Issue 7, 1996, Pages 1123-1129

  Vanden Heuvel, John P ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

fatty acid metabolism; gene expression; hypolipidemia; perfluorodecanoic acid; peroxisome proliferators

Indexed keywords

ANTILIPEMIC AGENT; CLOFIBRIC ACID; GEMFIBROZIL; HALOGENATED HYDROCARBON; PERFLUORODECANOIC ACID; PEROXISOME PROLIFERATOR; PHTHALIC ACID ESTER; SOLVENT;

DISEASE ASSOCIATION; DISORDERS OF PEROXISOMAL FUNCTIONS; DRUG MECHANISM; DRUG METABOLISM; FATTY ACID METABOLISM; GENE EXPRESSION; HUMAN; HYPOLIPEMIA; LIVER CELL CARCINOMA; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; REVIEW; RODENT;

EID: 0030273512     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)00126-3     Document Type: Review

References (56)

1. Aarsland A., Aarsaether N., Bremer J., and Berge R. K. (1989) Alkylthioacetic acids (3-thia fatty acids) as non-β-oxidizable fatty acid analogs, a new group of hypolipidemic drugs. III. Dissociation of cholesterol and triglyceride-lowering effects and the induction of peroxisomal β-oxidation. J. Lipid. Res. 30, 1711-1718.
2. Bookstaff R. C., Moore R. W., Ingall G. B., and Peterson R. E. (1990) Androgenic deficiency in male rats treated with perfluorodecanoic acid. Toxicol. Appl. Pharmac. 104, 322-333.
3. Borges T., Robertson L. W., Peterson R. E., and Glauert H. P. (1992) Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal beta-oxidation. Arch. Toxicol. 66, 18-22.
4. Borges T., Glauert H. P., and Robertson L. W. (1993a) Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase. Toxicol. Appl. Pharmac. 118, 8-15.
5. Borges T., Peterson R. E., Pitot H. C., Robertson L. W., and Glauert H. P. (1993b) Effect of the peroxisome proliferator perfluorodecanoic acid on the promotion of two-state hepatocarcinogenesis in rats. Cancer. Lett. 72, 111-120.
6. Bronfman M. (1986). Activation of hypolipidemic drugs to acyl-CoA thioesters. Biochem. J. 239, 781-784.
7. Cannon J. R., and Eacho P. I. (1991) Interaction of LY171883 and other peroxisome proliferators with fatty-acid-binding protein isolated from rat liver. Biochem. J. 280, 387-391.
8. Chen H., Huang C.-Y., Wilson M. W., Lay L. T., Robertson L. W., Chow C. K., and Glauert H. P. (1994) Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on cell proliferation and toxicity in Sprague-Dawley rats. Carcinogenesis 15, 2847-2850.
9. Cherkaoui M. M., Lone Y. C., Corral-Debrinski M., and Latruffe N. (1990) Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators. Biochem. Biophys. Res. Commun. 173, 855-861.
10. Clark L. C., Becattini F., Kaplan S., Obrock V., Cohen D., and Becker C. (1973) Perfluorocarbons having a short dwell in time in the liver. Science, 181, 680-682.
11. Conway J. G., Cattley R. C., Popp J. A., and Butterworth B. E. (1989a) Possible mechanisms in hepatocarcinogensis by the peroxisome proliferator Di(2-ethylhexyl)phthalate. Drug. Metab. Rev. 21, 65-102.
12. Conway J. G., Tomaszewski K. E., Olson M. J., Cattley R. C., Marsman D. S., and Popp J. A. (1989b) Relationship of oxidation damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)-phthalate and Wy-14,643. Carcinogenesis 10, 513-519.
13. Davis J. W., 2d, Vanden Heuvel J. P., and Peterson R. E. (1991) Effects of perfluorodecanoic acid on de novo fatty acid and cholesterol synthesis in the rat. Lipids 26, 857-859.
14. de Duve C., and Baudhuin P. (1966) Peroxisomes (microbodies and related particles). Physiol. Rev. 46, 186-194.
15. Dianzani M. U. (1979) In Toxic Injury in the liver Edited by Farber E. and Fisher, M. M. pp. 381-431. Marcel-Dekker. New York.
16. Dreyer C., Keller H., Mahfoudi A., Laudet V., Krey G., and Wahli W. (1993) Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors (PPAR). Biol. Cell. 77, 67-76.
17. Eacho P. I., and Foxworthy P. S. (1988) Inhibition of hepatic fatty acid oxidation by bezafibrate and bezafibroyl CoA. Biochem. biophys. Res. Commun. 157, 1148-1153.
18. George M. E., and Andersen M. E. (1986) Toxic effects of perfluoro-n-decanoic acid in rats. Toxicol. Appl. Pharmac. 85, 169-180.
19. Glauert H. P., Srinivasan S., Tatum V. L., Chen L. C., Szxon D. M., Lay L. T., Borges T., Baker M., Chen L. H., Robertson L. W., et al. (1992) Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats. Biochem. Pharmac. 43, 1353-1359.
20. Goecke C. M., Jarnot B. M., and Reo N. V. (1992) A comparative toxicological investigation of perfluorocarboxylic acids in rat by fluorine-19 NMR spectroscopy. Chem. Res. Toxicol. 5, 512-519.
21. Gottlicher M., Widmark E., Li Q., and Gustafsson J. A. (1992) Fatty acids activate a chimera of the clofibrate acid activated receptor and the glucocorticoid receptor. Proc. nat. Acad. Sci. U. S. A. 89, 4653-4657.
22. Green S. (1992) Nuclear receptors and chemical carcinogenesis. TIPS 13, 251-255.
23. Griffith F. D., and Long J. E. (1980) Animal toxicity studies with ammonium perfluorooctanoate. Am. J. Hyg. Assoc. J. 48, 576-583.
24. Hansen H. O., Andreasen P. H. Mandrup S., Kristiansen K., and Knudsen J. (1991) Induction of acyl-CoA-binding protein and its mRNA in 3T3-L1 cells by insulin during preadipocyte-to-adipocyte differentiation. Biochem. J. 277, 955-966.
25. Harrison E. H., Lane J. S., Luking S., Van Rafelghem M. J. and Andersen M. E. (1988) Perfluoro-n-decanoic acid: Induction of peroxisomal β-oxidation by a fatty acid with dioxin-like toxicity. Lipids 23, 115-119.
26. Henne A. L., and Fox C. J. (1951) Ionization constants of fluorinated acids. J. Am. Chem. Soc. 73, 2323-2325.
27. Hess R., Staubli W., and Reiss W. (1965) Nature of the hypolipidemic effect produced by ethyl-chlorophenxyisobutryate in the rat. Nature 208, 856-859.
28. Ikeda T., Aiba K., Fukuda K., and Tanaka M. (1985) The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J. Biochem. 98, 475-482.
29. Isseman I., and Green S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347, 645-650.
30. Issemann I., Prince P., Tugwood J., and Green S. (1992) A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation? Biochem. Soc. Trans. 20, 824-827.
31. Just W. W., Gorgas K., Hartl F.-U., Heinemann P., Salzer M., and Schimassek H. (1989) Biochemical effects and zonal heterogenety of peroxisome proliferation induced by perfluorocarboxylic acids in rat liver. Hepatology 9, 570-581.
32. Kawashima Y., Uy-Yu N., and Kozuka H. (1989) Sex-related difference in the inductions of perfluoro-octanoic acid of peroxisomal β-oxidation, microsomal 1-acylglycerolphosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver. Biochem. J. 261, 595-600.
33. Kelling C., Van Rafelghem M. J., Menahan L. A., and Peterson R. E. (1987) Effects of perfluorodecanoic acid on hepatic indices of thyroid status in the rat. Biochem. Pharmac. 36, 1337-1344.
34. Kham S. H., and Sorof S. (1994) Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc. nat. Acad. Sci. U. S. A. 91, 848-852.
35. Kuslikis B. I., Vanden H. J. P., and Peterson R. E. (1992) Lack of evidence for perfluorodecanoyl-or perfluorooctanoyl-coenzyme A formation in male and female rats. J. Biochem. Toxicol. 7, 25-29.
36. Lazarow P. B., and Fujiki Y. (1985) Biogenesis of peroxisomes. Ann. Rev. Cell. Biol. 1, 489-530.
37. Ledwith B. J., Manam S., Troilo P., Joslyn D. J., Galloway S. M., and Nichols W. W. (1993) Activation of immediate-early gene expression by peroxisome proliferators in vitro. Mol. Carcinog. 8, 20-27.
38. Marsman D. S., Cattley R. C., Conway J. G., and Popp J. A. (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinyl-thio]acetic acid (Wy-14,643) in rats. Cancer Res. 48, 6739-6744.
39. Moody D. E., Reddy J. K., Lake B. G., Popp J. A., and Reese D. H. (1991) Peroxisome proliferation and nongenotoxic carcinogenesis. Commentary on a symposium. Fundam. Appl. Toxicol. 16, 233-248.
40. Nelson D. L., Frazier D. E., Jr., Ericson J. E., Tarr M. J., and Mathes L. E. (1992) The effects of perfluorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in Fischer 344 rats. Immunopharmac. Immunotoxicol. 14, 925-938.
41. Olson C. T., and Andersen M. E. (1983) The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol. Appl. Pharmac. 70, 362-372.
42. Permadi H., Lundgren B., Andersson K., and DePierre J. W. (1992) Effects of perfluoro fatty acids on xenobiotic-metabolizing enzymes, enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver. Biochem. Pharmac. 44, 1183-1191.
43. Pilcher G. D., and Langley A. E. (1986) The effects of perfluoro-n-decanoic acid in the rat heart. Toxicol. Appl. Pharmac. 85, 389-397.
44. Schooley D. A., and Quistad G. B. (1983) Conjugation reactions of pesticide metabolites with lipids of animals. In Pesticide Chemistry: Human welfare and the environment, vol. 3, pp. 301-306. Edited by Matsunaka S., Hutson D. H., and Murphy S. D., Pergamon Press, New York.
45. Sterchele P. F., Vanden H. J. P., Davis J. W., 2nd., Shrago E., Knudsen J., and Peterson R. E. (1994) Induction of hepatic acyl-CoA-hinding protein and liver fatty acid-binding protein by perfluorodecanoic acid in rats. Lack of correlation with hepatic long-chain acyl-CoA levels. Biochem. Pharmac. 48, 955-966.
46. Tugwood J. D., Issemann I., Anderson R. G., Bundell K. R., McPheat W. L., and Green S. (1992). The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. Embo. J. 11, 433-439.
47. Vanden Heuvel J. P., Kuslikis B. I., Van Rafelghen M. J., and Peterson R. E. (1991a) Disposition of perfluorodecanoic acid in male and female rats. Toxicol. Appl. Pharmac. 107, 450-459.
48. Vanden Heuvel J. P., Kuslikis B. I., Shrago E., and Peterson R. E. (1991b) Inhibition of long-chain acyl-CoA synthetase by the peroxisome proliferator perfluorodecanoic acid in rat hepatocytes. Biochem. Pharmac. 42, 295-302.
49. Vanden Heuvel J. P., Kuslikis B. I., Van Rafelghem M. J., and Peterson R. E. (1991c) Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. J. Biochem. Toxicol. 6, 83-92.
50. Vanden Heuvel J. P., Sterchele P. F., Nesbit D. J., and Peterson R. E. (1993). Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators. Biochim. Biophys. Acta 1177, 183-190.
51. Van Rafelghem M. J., Mattie D. R., Bruner R. H., and Andersen M. E. (1987) Pathological and hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid in rat, hamster, mouse and guinea pig. Fundam. Appl. Toxicol. 9, 522-540.
52. Van Rafelghem M. J., Vanden Heuvel J. P., Menahan L. A., and Peterson R. E. (1988a) Perfluorodecanoic acid and lipid metabolism in the rat. Lipids 23, 671-678.
53. Van Rafelghem M. J., Noren C. W., Menahan L. A., and Peterson R. E. (1988b) Interrelationships between energy and fat metabolism and hypophagia in rats treated with perfluorodecanoic acid. Toxicol Lett. 40, 57-69.
54. Veerkamp J. H., Peters R. A., and Maatman R. G. H. J. (1991) Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim. Biophys. Acta 1081, 1-24.
55. Witzmann F. A., and Parker D. N. (1991) Hepatic protein pattern alterations following perfluorodecanoic acid exposure in rats. Toxicol. Lett. 57, 29-36.
56. Ylinen M., Kojo A., Hanhijarva H., and Peura P. (1990) Disposition of perflurooctanoic acid in rat after a single and subchronic administration. Bull. Environ. Contam. Toxicol. 44, 46-53.